<code id='85E12FF62C'></code><style id='85E12FF62C'></style>
    • <acronym id='85E12FF62C'></acronym>
      <center id='85E12FF62C'><center id='85E12FF62C'><tfoot id='85E12FF62C'></tfoot></center><abbr id='85E12FF62C'><dir id='85E12FF62C'><tfoot id='85E12FF62C'></tfoot><noframes id='85E12FF62C'>

    • <optgroup id='85E12FF62C'><strike id='85E12FF62C'><sup id='85E12FF62C'></sup></strike><code id='85E12FF62C'></code></optgroup>
        1. <b id='85E12FF62C'><label id='85E12FF62C'><select id='85E12FF62C'><dt id='85E12FF62C'><span id='85E12FF62C'></span></dt></select></label></b><u id='85E12FF62C'></u>
          <i id='85E12FF62C'><strike id='85E12FF62C'><tt id='85E12FF62C'><pre id='85E12FF62C'></pre></tt></strike></i>

          knowledge

          knowledge

          author:explore    Page View:1

          Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

          This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.  

          advertisement

          To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          knowledge

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          As JPM 2024 winds down, some health tech firms project optimism
          As JPM 2024 winds down, some health tech firms project optimism

          AdobeYou’rereadingthewebeditionofSTAT’sHealthTechnewsletter,ourguidetohowtechnologyistransformingthe

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Telehealth startups are trying to fill the menopause care vacuum

          MollyFergusonforSTATAttheturnofthecentury,nearly18millionwomenintheUnitedStateswerebattlinghotflashe